- Home
- BALL vs ELAN Comparison
BALL vs ELAN Comparison
Compare BALL & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BALL
- ELAN
- Stock Information
- Founded
- BALL 1880
- ELAN 1954
- Country
- BALL United States
- ELAN United States
- Employees
- BALL N/A
- ELAN N/A
- Industry
- BALL Containers/Packaging
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- BALL Industrials
- ELAN Health Care
- Exchange
- BALL Nasdaq
- ELAN Nasdaq
- Market Cap
- BALL 12.8B
- ELAN 10.3B
- IPO Year
- BALL N/A
- ELAN 2018
- Fundamental
- Price
- BALL $47.00
- ELAN $22.15
- Analyst Decision
- BALL Buy
- ELAN Buy
- Analyst Count
- BALL 12
- ELAN 8
- Target Price
- BALL $63.27
- ELAN $20.00
- AVG Volume (30 Days)
- BALL 2.7M
- ELAN 4.7M
- Earning Date
- BALL 11-04-2025
- ELAN 11-05-2025
- Dividend Yield
- BALL 1.70%
- ELAN N/A
- EPS Growth
- BALL N/A
- ELAN N/A
- EPS
- BALL 1.90
- ELAN 0.88
- Revenue
- BALL $12,397,000,000.00
- ELAN $4,484,000,000.00
- Revenue This Year
- BALL $10.84
- ELAN $5.77
- Revenue Next Year
- BALL $3.21
- ELAN $4.96
- P/E Ratio
- BALL $23.62
- ELAN $25.31
- Revenue Growth
- BALL 4.64
- ELAN N/A
- 52 Week Low
- BALL $43.51
- ELAN $8.02
- 52 Week High
- BALL $64.80
- ELAN $22.86
- Technical
- Relative Strength Index (RSI)
- BALL 33.45
- ELAN 67.07
- Support Level
- BALL $46.64
- ELAN $21.80
- Resistance Level
- BALL $50.35
- ELAN $22.86
- Average True Range (ATR)
- BALL 0.87
- ELAN 0.60
- MACD
- BALL -0.05
- ELAN 0.02
- Stochastic Oscillator
- BALL 15.44
- ELAN 78.15
About BALL Ball Corporation
Ball is the world's largest metal can manufacturer with market share over 30% in its three main regions (North America, Europe, and South America). The company is focused on increasing capacity amid a wave of new developed-market demand, while also investing in faster-growing emerging-market economies. Ball spun-off its glass jar business in 1993 and is now owned by Newell. The company reports three segments—beverage packaging, North and Central America (48% of 2024 revenue), beverage packaging, EMEA (29%), beverage packaging, South America (17%)—and it generated $12 billion in revenue in 2024.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.